MedTrace Logo

HYPOPhosphatemia in the Intensive Care: A One-day Point Prevalence Survey

NCT04201899 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 890

Last updated 2021-02-02

No results posted yet for this study

Summary

The point prevalence survey aims at defining the until now unknown real prevalence of hypophosphatemia (defined as blood phosphate value \< 0.8 mmol/l) in international critical care settings

Conditions

  • Critically Ill

Interventions

DIETARY_SUPPLEMENT

No intervention - pure observation

Phosphate administration (yes or no)

Sponsors & Collaborators

  • European Society of Intensive Care Medicine

    collaborator OTHER

  • Centre Hospitalier Universitaire Vaudois

    lead OTHER

Principal Investigators

  • Mette M BERGER, MD PhD · Lausanne University Hospital, Lausanne, Switzerland

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-09
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • Estonia
  • France
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04201899 on ClinicalTrials.gov